Dexcom Patent Invalidated In UPC's 2nd Merits Ruling
The Unified Patent Court ruled on Thursday that a patent for continuous glucose monitoring technology that Dexcom had accused rival Abbott of infringing was invalid, in the young court's second-ever ruling...To view the full article, register now.
Already a subscriber? Click here to view full article